ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.75
0.53%
US Tech 100
20,483.20
-0.34%
S&P 500
5,983.99
-0.29%
US Dollar vs CAD
1.39487
0.19%
Bitcoin
88,064.08
-0.78%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Valirx Plc (VAL) Share Price

Valirx Plc

Valirx Plc (VAL)

Valor Resources Limited
ETF
Amundi MSCI EMU Value Factor UCITS ETF Dist
Valaris Limited
1.525
0.00
(0.00%)
Closed November 12 10:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
1.525
Bid
1.45
Ask
1.60
Volume
16,914
1.525 Day's Range 1.525
1.225 52 Week Range 13.125
Market Cap
2.018M
Previous Close
1.525
Open
1.525
Last Trade
6688
@
1.525
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
899,020
Shares Outstanding
132,348,673
Dividend Yield
-
PE Ratio
-0.99
Earnings Per Share (EPS)
-0.02
Revenue
9k
Net Profit
-2.04M

About Valirx Plc

Sector
Medical Laboratories
Industry
Medical Laboratories
Headquarters
, Gbr
Founded
-
Valirx Plc is listed in the Medical Laboratories sector of the London Stock Exchange with ticker VAL. The last closing price for Valirx was 1.53p. Over the last year, Valirx shares have traded in a share price range of 1.225p to 13.125p.

Valirx currently has 132,348,673 shares outstanding. The market capitalization of Valirx is £2.02 million. Valirx has a price to earnings ratio (PE ratio) of -0.99.

Ask ADVFN Intelligence (AI)

VAL Latest News

More News

ValiRx PLC Update on proposed sub-license of VAL201

ValiRx PLC 30 October 2024   30 October 2024   ValiRx PLC ("ValiRx" or the "Company")   Update on proposed sub-license of VAL201   London, UK - ValiRx Plc (AIM: VAL), a life science company...

October 30 2024
RNS Regulatory News

ValiRx PLC Directorate Change

ValiRx PLC 18 October 2024   ValiRx plc   ("ValiRx" or the "Company")   Directorate Change   ValiRx plc (AIM: VAL), a life sciences company focusing on early-stage cancer therapeutics and...

October 18 2024
RNS Regulatory News

ValiRx PLC Investor Webinar

ValiRx PLC 14 October 2024   ValiRx plc   ("ValiRx" or the "Company")   Investor Webinar   ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women's...

October 14 2024
RNS Regulatory News

ValiRx PLC Inaphaea Co-Marketing Agreement

ValiRx PLC 07 October 2024   ValiRx plc   ("ValiRx" or the "Company")   Inaphaea Co-Marketing Agreement   London, UK - ValiRx Plc (AIM: VAL), a life science company focusing on early-stage...

October 07 2024
RNS Regulatory News

EARNINGS: Kendrick Resources loss narrows; Emmerson CFO to depart

The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by ...

September 27 2024
Alliance News

ValiRx PLC Half-year Report

ValiRx PLC 27 September 2024       VALIRX PLC ("ValiRx", "the Company" or "the Group")   HALF YEARLY REPORT FOR THE PERIOD ENDED 30 JUNE 2024   London, UK., 2024: ValiRx Plc (AIM: VAL), a life...

September 27 2024
RNS Regulatory News

ValiRx PLC Conclusion of Evaluation Project

ValiRx PLC 26 September 2024   26 September 2024   ValiRx PLC ("ValiRx" or the "Company")   Conclusion of Evaluation Project   London, UK - ValiRx Plc (AIM: VAL), a life science company...

September 26 2024
RNS Regulatory News

ValiRx PLC Inaphaea Co-Marketing Agreement

ValiRx PLC 24 September 2024   ValiRx plc   ("ValiRx" or the "Company")   Inaphaea Co-Marketing Agreement   London, UK - ValiRx Plc (AIM: VAL), a life science company focusing on early-stage...

September 24 2024
RNS Regulatory News

ValiRx PLC Inaphaea Evaluation and Commercial Use Agreement

ValiRx PLC 18 September 2024   ValiRx plc   ("ValiRx" or the "Company")   Inaphaea Evaluation and Commercial Use Agreement   London, UK - ValiRx Plc (AIM: VAL), a life science company focusing...

September 18 2024
RNS Regulatory News

ValiRx PLC Inaphaea Co-Marketing Agreement

ValiRx PLC 16 September 2024   ValiRx plc   ("ValiRx" or the "Company")   Inaphaea Co-Marketing Agreement   London, UK - ValiRx Plc (AIM: VAL), a life science company focusing on early-stage...

September 16 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.175-10.29411764711.71.71.5251042751.53333744DE
40.275221.252.31.2514007241.91305406DE
12-0.875-36.45833333332.42.451.2258990201.8482861DE
26-1.525-503.054.351.22512392062.63489654DE
52-10.6-87.422680412412.12513.1251.22510293553.72836577DE
156-32.725-95.547445255534.2544.251.22587217811.11411294DE
260-3.675-70.67307692315.267.51.22531455769.62908868DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STARStar Energy Group Plc
9.50p
(37.09%)
8.53M
MNRGMetalnrg Plc
0.425p
(34.92%)
224.32M
PALMPanther Metals Plc
120.00p
(23.08%)
94.09k
CTECConvatec Group Plc
262.60p
(21.24%)
17.51M
WBIWoodbois Limited
0.315p
(18.87%)
68.38M
PPSProton Motor Power Systems Plc
0.475p
(-40.63%)
8.54M
ADFFacilities By Adf Plc
31.75p
(-39.18%)
20.45M
MSYSMicrosaic Systems Plc
0.85p
(-20.93%)
2.39M
GFINGfinity Plc
0.02p
(-20.00%)
83M
CRTMCritical Metals Plc
1.10p
(-15.38%)
755.83k
NTVONativo Resources Plc
0.0023p
(-8.00%)
2.96B
MSMNMosman Oil And Gas Limited
0.038p
(-2.56%)
1.09B
TRPTower Resources Plc
0.0275p
(3.77%)
307.51M
PREMPremier African Minerals Limited
0.031p
(-10.66%)
229.05M
MNRGMetalnrg Plc
0.425p
(34.92%)
224.32M

Discussion

View Full Feed
The_Gman The_Gman 2 minutes ago
Space. The difference between witnessing a kid napping....and a kidnapping.

Yeah, that's where the pic came from.
NB
ignatiusrielly35 ignatiusrielly35 2 minutes ago
You have no information as to when specifically the ATM is used. Period. In fact, I recall you attributing a price dip earlier this year to dilution in one quarter and the 10q showed virtually none. I repeat, blind guess.
AVXL
12yearplan 12yearplan 2 minutes ago
Sorry for the late reply; .. from your two links and thanks..
 
Summary.
 
Since the early 1970s, hourly inflation-adjusted wages received by the typical worker have barely risen, growing only 0.2% per year. Assigning relative responsibility to the policies and economic f
navycmdr navycmdr 2 minutes ago
https://x.com/InvestIt3/status/1856406733754708460
FNMA
2B_unknown 2B_unknown 2 minutes ago
Yes, we have had the golden ticket for some time now:)

We got this thing, just a matter of time.
NWBO
Hosai Hosai 3 minutes ago
From what I can see based on historical EMA review start dates in late 22 and 23 and aided by chat GPT it guesses the last 2 EMA review start dates for 2024 will be Nov 28th and Dec 27th.
If Anavex were to be aiming for the Nov 28th (ish) it would need to submit any time now. Obv though even
AVXL
MartinLutherKing MartinLutherKing 3 minutes ago
It just hit the wires brother
https://www.forbes.com/sites/jessicaourisman/2024/11/12/the-firsthand-results-of-a-nanofat-treatment-using-stem-cells-and-prp/
ELAB
manibiotech manibiotech 3 minutes ago
Yep nothing for market to be in any FOMO mode 
Likely will slowly go down over next few days without news . As I also said after ASM
ASM
Groveman1 Groveman1 3 minutes ago
Lucky, There's a new response on StockRunners twitter site today 11/12/24 on LLBO. Please check it and see if you can understand what this means for LLBO. StockRunners talks about attorneys and filing papers, but seems to be speaking about the other Company attached to the Post. Check it out.
LLBO
FeMike FeMike 4 minutes ago
I think they would rather say the inspection is completed even if the 10-q is up to September 30 only. If it's done by now since the q was prepared this nov. Therefore, it is not completed up to now.

My personal opinion is that saying "the inspections have been completed" is a bit too
NWBO
cottonisking cottonisking 4 minutes ago
No, peanuts and small money, compared to this board waiting here since 2008 and going through United States' Presidents and nut cases. Shut this mental ward down now. These guys have nothing better to do. Most must be in their 80s.
LEHNQ
northam43 northam43 4 minutes ago
Report #2 October 2024 SPX Cycles

https://investorshub.advfn.com/uimage/uploads/2024/11/12/inz[o2_Completed_Cycles.PNG
manibiotech manibiotech 5 minutes ago
Look at section subsequent events in 10 q

Hmm
NWBO
jimr1717 jimr1717 5 minutes ago
New Tesla Involved in a Crash While on FSD, the Teslacam Footage Was All Police Needed
3 Nov 2024, 22:00 UTC •

Bob claims that the moment the pickup truck slammed into his rear end, the FSD turned the steering wheel to the left to prevent his Tesla from hitting the vehicle wait
TSLA
MRJ25 MRJ25 5 minutes ago
Reddit will be better.
FNMA
Rebel13 Rebel13 5 minutes ago
There’s a saying about not being able to find your a$$ even if handed to you. Didn’t realize you were real!
ELTP
art2426 art2426 6 minutes ago
We're not getting into politics? Really? Who exactly brought THIS up? ---- "Especially with the new pro small business President we just elected!"


How is reading this board, NOT FUN?
BIEL
jimr1717 jimr1717 6 minutes ago
How? Watch and learn.
TSLA
mrwrn2010 mrwrn2010 6 minutes ago
Blast from the past!
ELTP
Mactheriverrat Mactheriverrat 7 minutes ago
Thoughts on TLRY?
TLRY
exwannabe exwannabe 7 minutes ago
Reimbursement. The Company has evaluated and selected specialized, highly experienced consultants with whom to undertake preparations for a potential reimbursement review ...
In other words, not even close to submitting the evidence that kicks off the NICE process.
NWBO
gdog gdog 7 minutes ago
11-12 buy/cover EVH $14.19 + 4.15%
MahinAgency MahinAgency 8 minutes ago
H.C. Wainwright maintains a "Buy" rating for Cardiol Therapeutics with a price target of $9.00.

MAVERIC-2 trial aims to assess CardiolRx in recurrent pericarditis patients post-IL-1 blocker therapy.
CRDL
againstallodds againstallodds 8 minutes ago
Market expects gold delivery, imagine if no delivery

No gold = no created value
NBRI
CommodityCoverage CommodityCoverage 8 minutes ago
Developing therapeutic compounds for pediatric diseases with unmet medical needs and a large addressable market, clinical-stage biotech company Thiogenesis Therapeutics (TTI.v), recently announced the approval of its European patent for the treatment of Cysteamine Sensitive Disorders, a medical cond
TTI

Your Recent History

LSE
VAL
Valirx
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved